Stock Overview
Moderna Inc (MRNA)
NASDAQ · Healthcare · Biotechnology
Moderna Inc is a Healthcare company with a market capitalization of $26.69B.
Market Cap
$26.69B
Forward P/E
23.0
Price/Sales
12.0
Price/Book
3.2
EV/EBITDA
4.6
Beta
1.03
EPS (TTM)
$-8.14
Profit Margin
-143.5%
ROE
-36.6%
52W High
$69.28
52W Low
$22.28
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Revenue
$1.94B
Gross Profit
$1.08B
Operating Income
-$3.07B
Net Income
-$2.82B
Free Cash Flow
-$2.06B
Total Debt
$590.00M
Cash & Equivalents
$2.60B
Shareholder Equity
$8.65B
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 1, 2026 | $-3.40 | $-2.11 | -61.1% |
| Q4 2025 | February 13, 2026 | $-2.11 | $-2.60 | +18.9% |
| Q3 2025 | November 6, 2025 | $-0.51 | $-2.16 | +76.4% |
| Q2 2025 | August 1, 2025 | $-2.13 | $-2.97 | +28.3% |
| Q1 2025 | May 1, 2025 | $-2.52 | $-3.11 | +19.0% |
| Q4 2024 | February 14, 2025 | $-2.91 | $-2.76 | -5.4% |
Other Biotechnology Stocks
Frequently Asked Questions
What is Moderna Inc's market cap?
As of June 29, 2026, Moderna Inc (MRNA) has a market capitalization of $26.69B.
Does Moderna Inc pay a dividend?
Moderna Inc does not currently pay a dividend.
What sector is MRNA in?
Moderna Inc is in the Healthcare sector, specifically the Biotechnology industry.
What was Moderna Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Moderna Inc reported revenue of $1.94B and net income of -$2.82B.
Ask your own questions about MRNA
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.